Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, 69120, Heidelberg, Germany.
DNA Repair Mechanisms and Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Nat Commun. 2020 Nov 2;11(1):5508. doi: 10.1038/s41467-020-19326-3.
The ubiquitous redox coenzyme nicotinamide adenine dinucleotide (NAD) acts as a non-canonical cap structure on prokaryotic and eukaryotic ribonucleic acids. Here we find that in budding yeast, NAD-RNAs are abundant (>1400 species), short (<170 nt), and mostly correspond to mRNA 5'-ends. The modification percentage of transcripts is low (<5%). NAD incorporation occurs mainly during transcription initiation by RNA polymerase II, which uses distinct promoters with a YAAG core motif for this purpose. Most NAD-RNAs are 3'-truncated. At least three decapping enzymes, Rai1, Dxo1, and Npy1, guard against NAD-RNA at different cellular locations, targeting overlapping transcript populations. NAD-mRNAs are not translatable in vitro. Our work indicates that in budding yeast, most of the NAD incorporation into RNA seems to be disadvantageous to the cell, which has evolved a diverse surveillance machinery to prematurely terminate, decap and reject NAD-RNAs.
普遍存在的氧化还原辅酶烟酰胺腺嘌呤二核苷酸(NAD)在原核和真核生物的核糖核酸上充当非典型的帽结构。在这里,我们发现,在芽殖酵母中,NAD-RNAs 丰富(>1400 种)、短(<170nt),并且主要对应于 mRNA 5'端。修饰转录本的百分比较低(<5%)。NAD 的掺入主要发生在 RNA 聚合酶 II 起始转录期间,聚合酶 II 使用具有 YAAG 核心基序的独特启动子来实现这一目的。大多数 NAD-RNAs 是 3'-截断的。至少有三种脱帽酶(Rai1、Dxo1 和 Npy1)在不同的细胞位置对 NAD-RNA 进行防护,针对重叠的转录本群体。NAD-mRNAs 在体外不可翻译。我们的工作表明,在芽殖酵母中,RNA 中大多数 NAD 的掺入似乎对细胞不利,细胞已经进化出多种监测机制来过早终止、脱帽和拒绝 NAD-RNAs。